Showing 11,341 - 11,360 results of 24,223 for search '(( 50 ((mean decrease) OR (nn decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 0.87s Refine Results
  1. 11341

    Synthesized traces from the strongest harmonics of the original signal. by Sorinel A. Oprisan (3851089)

    Published 2019
    “…All distributions of residuals, i.e. the difference between the original and the synthesized signal, have Gaussian shapes (a2 and b2). The amplitude or residuals decreases by an order of magnitude as the number of frequencies for the synthesized signal increased from 3 (a2) to 100 (b2).…”
  2. 11342

    Table 1_Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transpla... by Tatiana A. Rudakova (20945432)

    Published 2025
    “…</p>Results<p>Overall survival at 100 days was 57% (95%CI, 36–90). The cumulative incidence of LDH decreased by 25% was 89% (95% CI, 26–99) with a median time of 11 days (range: 2–27). …”
  3. 11343

    Table 2_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  4. 11344

    Table 10_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  5. 11345

    Table 6_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  6. 11346

    Table 1_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  7. 11347

    Table 11_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  8. 11348

    Table 13_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  9. 11349

    Table 9_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  10. 11350

    Table 4_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  11. 11351

    Table 7_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  12. 11352

    Table 3_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  13. 11353

    Table 8_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  14. 11354

    Table 12_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  15. 11355

    Table 5_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

    Published 2024
    “…</p>Methods<p>Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. …”
  16. 11356
  17. 11357

    Supplementary file 1_Global burden of childhood otitis media attributable to secondhand smoke from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.pd... by Bei Li (90587)

    Published 2025
    “…</p>Results<p>The global YLDs due to childhood otitis media attributable to SHS decreased by 17.65% in 1990–2021. The ASYR decreased by 28.78%, from 5.49 [95% uncertainty interval (UI): 2.38–9.9] per 100,000 to 3.91 (95% UI: 1.66–7.23) per 100,000. …”
  18. 11358

    Photochromism of 1,2-Bis(2-ethyl-5-phenyl-3-thienyl)perfluorocyclopentene in a Single-Crystalline Phase. Conrotatory Thermal Cycloreversion of the Closed-Ring Isomer by Seiya Kobatake (1628683)

    Published 2000
    “…The thermal cycloreversion activation energies were measured in the toluene solution and in the single-crystalline phase above 100 °C. The activation energy from photogenerated <b>1b</b> to <b>1a</b> in the solution was 128 kJ mol<sup>-1</sup>, while it decreased to 120 kJ mol<sup>-1</sup> in the crystal of the open-ring isomer <b>1a</b>. …”
  19. 11359

    T and related Tbx factors reduce Mixl1 induction of the <i>Gsc</i> promoter. by Lloyd A. Pereira (194227)

    Published 2011
    “…C2C12 cells were co-transfected with 100 ng of a <i>pGL3</i> Gsc promoter-luciferase reporter construct, 25 ng pMT2-HA-Mixl1 and increasing amounts of pMT2-HA-T as indicated. …”
  20. 11360

    PDGFRβ contributes to <i>C. trachomatis</i> binding. by Cherilyn A. Elwell (43466)

    Published 2008
    “…The percentage of cell-associated bacteria was significantly decreased only in cells treated with a neutralizing antibody to PDGFRβ but not EGFR. …”